
Atopic Dermatitis Studies Christchurch
Christchurch
Momentum Clinical Research is looking for adults with moderate-to-severe atopic dermatitis, also known as eczema, for a clinical research study. The study will assess the safety of an investigational study medicine and learn how it affects eczema.
Description
What to expect
Ages
18-70
Duration
The study duration is up to 32 weeks, with approximately 13 scheduled clinic visits.
Compensation
Participants will be paid for time and study-related costs.
Eligibility Criteria
You may qualify for this study if you:
Other eligibility criteria apply. A member of our team will check whether the study may be suitable for you.
Locations
Atopic dermatitis, also known as eczema, is a long-term skin condition that may cause dry, itchy, sore or inflamed skin. Symptoms can affect comfort, sleep and everyday activities. Atopic dermatitis is commonly managed using topical treatments and other medicines, but symptoms may remain inadequately controlled for some people.
This study is assessing an investigational study medicine in adults with moderate-to-severe eczema. Researchers want to learn more about its safety and how it affects eczema when compared with placebo.
If you are eligible and choose to participate, you will be randomly assigned to receive either the investigational study medicine or placebo.
The study medicine or placebo will be given as injections under the skin at the clinic by our study clinical team. Participation will last up to 32 weeks and involve up to 13 scheduled clinic visits.
Study activities include health checks, physical examinations, blood and urine tests, pregnancy tests where applicable, heart checks, skin assessments and photographs of selected areas of eczema. You will also record information about itching and sleep and wear a study-provided sleep-monitoring ring.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research NZ is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. By clicking 'Submit' you agree to our Privacy Policy which contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.